Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP821639.RAQg6vRuupfIVCmmqX2NU9u5T3E_GGi6EiyX592RJzOBU130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP821639.RAQg6vRuupfIVCmmqX2NU9u5T3E_GGi6EiyX592RJzOBU130_provenance.
• NP662099.RAyzAYIvYAjkVVlSziwwZSQ_fEJqbv39J-tLvoWdJjYaA130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662099.RAyzAYIvYAjkVVlSziwwZSQ_fEJqbv39J-tLvoWdJjYaA130_provenance.
• NP597906.RAHY39MeACgXNrjZGjLYOU_oHSE4ZNvisvs6S_pMhyTag130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597906.RAHY39MeACgXNrjZGjLYOU_oHSE4ZNvisvs6S_pMhyTag130_provenance.
• NP1380902.RAAeivJQlgCHyRiwJZnYoN8MSWdo7te5V-d0vVD0aTBiI130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1380902.RAAeivJQlgCHyRiwJZnYoN8MSWdo7te5V-d0vVD0aTBiI130_provenance.
• NP776049.RARmjQk2vR8O1QozRBI4IaHEz-VskxTOquVTqJlEFp2MI130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776049.RARmjQk2vR8O1QozRBI4IaHEz-VskxTOquVTqJlEFp2MI130_provenance.
• NP686785.RAbRZxz6UwwnmNaJCekszLNqoVK3zXCj2pdTSu-RKQEx0130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686785.RAbRZxz6UwwnmNaJCekszLNqoVK3zXCj2pdTSu-RKQEx0130_provenance.
• NP776145.RAw7kgHnRnc3Y6yRDj24HcLO4kMiloh9ZZOBetBfoX1XY130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776145.RAw7kgHnRnc3Y6yRDj24HcLO4kMiloh9ZZOBetBfoX1XY130_provenance.
• NP1380904.RAyqaDhbr2s5Jj9BbMkuZ4HUyoDegrFfZTJPdlGHedrCw130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1380904.RAyqaDhbr2s5Jj9BbMkuZ4HUyoDegrFfZTJPdlGHedrCw130_provenance.
• NP1380905.RA2P1Dbp4Qr95qWP5DFYMQJtaE-6R5khKXpZzGhhc5KyI130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1380905.RA2P1Dbp4Qr95qWP5DFYMQJtaE-6R5khKXpZzGhhc5KyI130_provenance.
• NP1380906.RA8U5ml2UUwIb_5Rn5ZzieMzGGtP9tUpmSWuZdUQqmfRo130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1380906.RA8U5ml2UUwIb_5Rn5ZzieMzGGtP9tUpmSWuZdUQqmfRo130_provenance.
• NP1380907.RA_mAX1y-HeWbgGQxbVDfcvkqSIX280Ui5DhPW95UMtgY130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1380907.RA_mAX1y-HeWbgGQxbVDfcvkqSIX280Ui5DhPW95UMtgY130_provenance.
• assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP686817.RALxQLsYgQga8BQgKQuwoWlwrbFX_Wt8NjH96hFQ5w0w8130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686817.RALxQLsYgQga8BQgKQuwoWlwrbFX_Wt8NjH96hFQ5w0w8130_provenance.
• assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP686792.RAtNT18rLZe1EhF0PFVxmZoeoA3BFKcYs7A7uXxIfYF1Y130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686792.RAtNT18rLZe1EhF0PFVxmZoeoA3BFKcYs7A7uXxIfYF1Y130_provenance.
• NP776078.RArB_XLY7xDctdS-y7ogXUnHaZss75zEjRuI56Ea2zb2Q130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776078.RArB_XLY7xDctdS-y7ogXUnHaZss75zEjRuI56Ea2zb2Q130_provenance.
• NP1380903.RAgavLrRn0EDfE8Sa3S9T3CHhlxskMMUnSY1xeyTifCQc130_assertion description "[We compared sodium-lithium countertransport activity (SLC Vmax), plasma lipoprotein(a) and von Willebrand factor (vWf) concentrations, incidence of vascular disease, and incidence of hypertension in 37 first degree relatives of 23 patients with stable IgAN and 33 first degree relatives of 17 patients with progressive IgAN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1380903.RAgavLrRn0EDfE8Sa3S9T3CHhlxskMMUnSY1xeyTifCQc130_provenance.